2.3 USD
-0.06 (-2.54%)
We assign a fundamental rating of 1 out of 10 to EDAP. EDAP was compared to 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of EDAP have multiple concerns. While showing a medium growth rate, EDAP is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year EDAP has reported negative net income.
In the past year EDAP has reported a negative cash flow from operations.
EDAP had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: EDAP reported negative operating cash flow in multiple years.
1.2 Ratios
EDAP has a Return On Assets of -31.94%. This is comparable to the rest of the industry: EDAP outperforms 40.96% of its industry peers.
EDAP has a worse Return On Equity (-84.17%) than 62.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.94% | ||
| ROE | -84.17% | ||
| ROIC | N/A |
ROA(3y)-16.04%
ROA(5y)-10.06%
ROE(3y)-29.27%
ROE(5y)-18.58%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
EDAP's Gross Margin of 43.24% is on the low side compared to the rest of the industry. EDAP is outperformed by 64.89% of its industry peers.
In the last couple of years the Gross Margin of EDAP has declined.
EDAP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.24% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-2.4%
2. Health
2.1 Basic Checks
EDAP does not have a ROIC to compare to the WACC, probably because it is not profitable.
EDAP has more shares outstanding than it did 1 year ago.
The number of shares outstanding for EDAP has been increased compared to 5 years ago.
EDAP has a worse debt/assets ratio than last year.
2.2 Solvency
A Debt/Equity ratio of 0.26 indicates that EDAP is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.26, EDAP perfoms like the industry average, outperforming 54.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACC7.54%
2.3 Liquidity
EDAP has a Current Ratio of 1.41. This is a normal value and indicates that EDAP is financially healthy and should not expect problems in meeting its short term obligations.
EDAP's Current ratio of 1.41 is on the low side compared to the rest of the industry. EDAP is outperformed by 78.72% of its industry peers.
EDAP has a Quick Ratio of 1.41. This is a bad value and indicates that EDAP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of EDAP (0.97) is worse than 79.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.41 | ||
| Quick Ratio | 0.97 |
3. Growth
3.1 Past
EDAP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.86%, which is quite good.
The Revenue has been growing slightly by 0.13% in the past year.
Measured over the past years, EDAP shows a small growth in Revenue. The Revenue has been growing by 7.38% on average per year.
EPS 1Y (TTM)11.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.53%
Revenue 1Y (TTM)0.13%
Revenue growth 3Y13.31%
Revenue growth 5Y7.38%
Sales Q2Q%5.96%
3.2 Future
Based on estimates for the next years, EDAP will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.64% on average per year.
The Revenue is expected to grow by 17.06% on average over the next years. This is quite good.
EPS Next Y-41.53%
EPS Next 2Y-17.33%
EPS Next 3Y4.48%
EPS Next 5Y18.64%
Revenue Next Year-6.7%
Revenue Next 2Y-5.12%
Revenue Next 3Y-0.19%
Revenue Next 5Y17.06%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
EDAP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EDAP. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.33%
EPS Next 3Y4.48%
5. Dividend
5.1 Amount
EDAP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:EDAP (11/21/2025, 8:24:39 PM)
2.3
-0.06 (-2.54%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners37.83%
Inst Owner Change-1.97%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap85.34M
Revenue(TTM)63.80M
Net Income(TTM)-19.63M
Analysts77.78
Price Target5.95 (158.7%)
Short Float %0.1%
Short Ratio0.61
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.42%
Min EPS beat(2)7.96%
Max EPS beat(2)40.88%
EPS beat(4)3
Avg EPS beat(4)19.08%
Min EPS beat(4)-23.38%
Max EPS beat(4)50.84%
EPS beat(8)3
Avg EPS beat(8)-24.52%
EPS beat(12)3
Avg EPS beat(12)-303.5%
EPS beat(16)7
Avg EPS beat(16)-180.95%
Revenue beat(2)2
Avg Revenue beat(2)5.63%
Min Revenue beat(2)5.32%
Max Revenue beat(2)5.94%
Revenue beat(4)3
Avg Revenue beat(4)0.41%
Min Revenue beat(4)-12.67%
Max Revenue beat(4)5.94%
Revenue beat(8)4
Avg Revenue beat(8)-1.45%
Revenue beat(12)5
Avg Revenue beat(12)-3.55%
Revenue beat(16)7
Avg Revenue beat(16)-1.94%
PT rev (1m)1.15%
PT rev (3m)1.45%
EPS NQ rev (1m)18.96%
EPS NQ rev (3m)-1.2%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.73%
Revenue NQ rev (1m)1.25%
Revenue NQ rev (3m)2.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.16 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.18 | ||
| P/tB | 3.54 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.6
EYN/A
EPS(NY)-0.79
Fwd EYN/A
FCF(TTM)-0.51
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS1.98
BVpS0.72
TBVpS0.65
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.94% | ||
| ROE | -84.17% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.24% | ||
| FCFM | N/A |
ROA(3y)-16.04%
ROA(5y)-10.06%
ROE(3y)-29.27%
ROE(5y)-18.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-2.4%
F-Score4
Asset Turnover1.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 189.75% | ||
| Cap/Sales | 7.63% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.41 | ||
| Quick Ratio | 0.97 | ||
| Altman-Z | N/A |
F-Score4
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)176.18%
Cap/Depr(5y)116.88%
Cap/Sales(3y)5.91%
Cap/Sales(5y)4.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.53%
EPS Next Y-41.53%
EPS Next 2Y-17.33%
EPS Next 3Y4.48%
EPS Next 5Y18.64%
Revenue 1Y (TTM)0.13%
Revenue growth 3Y13.31%
Revenue growth 5Y7.38%
Sales Q2Q%5.96%
Revenue Next Year-6.7%
Revenue Next 2Y-5.12%
Revenue Next 3Y-0.19%
Revenue Next 5Y17.06%
EBIT growth 1Y-0.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-9.58%
EBIT Next 3Y-1.85%
EBIT Next 5YN/A
FCF growth 1Y6.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.45%
OCF growth 3YN/A
OCF growth 5YN/A
EDAP TMS SA -ADR / EDAP FAQ
What is the fundamental rating for EDAP stock?
ChartMill assigns a fundamental rating of 1 / 10 to EDAP.
What is the valuation status of EDAP TMS SA -ADR (EDAP) stock?
ChartMill assigns a valuation rating of 0 / 10 to EDAP TMS SA -ADR (EDAP). This can be considered as Overvalued.
Can you provide the profitability details for EDAP TMS SA -ADR?
EDAP TMS SA -ADR (EDAP) has a profitability rating of 1 / 10.
What is the expected EPS growth for EDAP TMS SA -ADR (EDAP) stock?
The Earnings per Share (EPS) of EDAP TMS SA -ADR (EDAP) is expected to decline by -41.53% in the next year.